Jia Qingqing, Wei Youfei, Hu Yulin, Yang Yuexin, Hong Wenxin, Huang Huiying, Lin Quankui
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.
National Engineering Research Center of Ophthalmology and Optometry, School of Biomedical Engineering, School of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China.
Acta Biomater. 2025 Jan 15;192:248-259. doi: 10.1016/j.actbio.2024.12.016. Epub 2024 Dec 5.
Posterior capsule opacification (PCO) is the most common complication after cataract surgery. It is primarily caused by the proliferation, migration, and adhesion of residual lens epithelial cells within the capsular bag following phacoemulsification and intraocular lens (IOL) implantation. Although investigations of surface modification onto IOL have partially reduced PCO development in recent years, there are still challenges in long-term efficacy and intraocular biocompatibility. In this study, a cascade catalytic system is constructed using natural enzymes onto mesoporous silica nanoparticles (MSNs), which are subsequently fixed to the surface of IOL through layer-by-layer self-assemble of alternating positive and negative charges. The cascade catalytic reaction is trigged simply by glucose within the pouch to produce reactive oxygen species (ROS) without introducing any toxic drugs or external energy, attempting to minimize the possible toxic side effects to surrounding tissues. In vivo and in vitro experiments indicate the effective inhibition of PCO and favorable intraocular compatibility of the cascade catalytic platform modified IOL. More importantly, the modified IOL retains good optical performance and imaging quality, demonstrating promising prospects for application. This study provides a new possibility for enhanced and safer PCO prevention, playing great significance in clinical treatment. STATEMENT OF SIGNIFICANCE: Cascade catalytic nanoparticles-loaded multilayer modified IOL is obtained via LbL technique. The multilayer coating improves both the loading capacity and the activity of the cascade catalytic nanoparticles. The cascade catalytic reaction is trigged by glucose, producing ROS that efficiently induces apoptosis and death of remaining cells on IOL without introducing any toxic drugs or external energy. The innovative IOL provides a promising approach for enhanced and safer prevention of PCO.
后囊膜混浊(PCO)是白内障手术后最常见的并发症。它主要由超声乳化和人工晶状体(IOL)植入后囊袋内残留晶状体上皮细胞的增殖、迁移和黏附引起。尽管近年来对IOL表面改性的研究在一定程度上减少了PCO的发生,但在长期疗效和眼内生物相容性方面仍存在挑战。在本研究中,利用天然酶在介孔二氧化硅纳米颗粒(MSNs)上构建了一种级联催化系统,随后通过正负电荷交替的层层自组装将其固定在IOL表面。囊袋内的葡萄糖即可简单触发级联催化反应以产生活性氧(ROS),无需引入任何有毒药物或外部能量,试图将对周围组织可能的毒副作用降至最低。体内和体外实验表明,级联催化平台修饰的IOL对PCO有有效抑制作用且具有良好的眼内相容性。更重要的是,修饰后的IOL保持了良好的光学性能和成像质量,展现出广阔的应用前景。本研究为增强和更安全地预防PCO提供了新的可能性,在临床治疗中具有重要意义。重要意义声明:通过层层技术获得了负载级联催化纳米颗粒的多层修饰IOL。多层涂层提高了级联催化纳米颗粒的负载能力和活性。级联催化反应由葡萄糖触发,产生ROS,可有效诱导IOL上残留细胞的凋亡和死亡,而无需引入任何有毒药物或外部能量。这种创新的IOL为增强和更安全地预防PCO提供了一种有前景的方法。